Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy?

Document first published:
Page updated:
Topic:
,
Publication type:

The aim of this research by White et al (2011) was to explore factors that influence the identification of treatment-induced female sexual “difficulties” in routine oncology follow-up after radical pelvic radiotherapy.

Link

Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy?

Assessment of treatment-induced female sexual morbidity in oncology: is this a part of routine medical follow-up after radical pelvic radiotherapy?

NHS England is not responsible for content on external websites.

Summary

This nurse-led study identified that female sexual morbidity after pelvic radiotherapy is not an addressed aspect of routine follow-up and cancer survivorship. The author recommends that development in both individual practice and service provision would improve the identification and management of treatment-induced female sexual difficulties. They report that addressing these factors, will provide better outcomes for female cancer survivors and give them better experiences.